Posts Tagged ‘dementia’

Questions Raised Over Antipsychotic Usage On Elderly

Thursday, March 3rd, 2011

Groups Trying To Prevent Misuse Of Psychoactive Drugs On Elderly Patients

10News.com- San Diego

March, 2, 2011

The 10News I-Team has learned many local skilled nursing facilities are using powerful drugs to control elderly patients’ behavior.Keith Blair suffered from mild dementia, and it wasn’t until after his death that his daughter, Marian Hollingsworth, realized he’d been given antipsychotic drugs.

“It’s a way of controlling them. It keeps him in bed,” said Hollingsworth.Until that realization, Hollingsworth was puzzled by her father’s rapid deterioration. He had been given the powerful antispychotics Risperdal and Haldol without her permission.”Antipsychotic drugs are for the treatment of mental illness, not dementia,” said Tony Chicotel of California Advocates for Nursing Home Reform (CANHR). “And now we’ve got studies that show just horrific outcomes for people with dementia who take these drugs and that they’re prescribed just as much as they ever were, if not more.

CANHR is trying to end the misuse of psychoactive drugs to control seniors. The group created a website which allows anyone to see how many patients are receiving psychoactive drugs at any skilled nursing facility in California. Experts say while using these drugs is sometimes justified, there are dangers in their misuse.”When you see nursing homes that are above 90 percent of their residents are receiving a psychotropic drug, you’re wondering what the hell is going on there,” said Chicotel.
read the rest of the story here: http://www.10news.com/news/27059153/detail.html

Visit the California Association for Nursing Home Reform website for their Campaign to Stop Chemical Restraints in Nursing Homes

http://www.canhr.org/stop-drugging/

« Return to news items


Share

Senate Aging Panel Blows Whistle on Over Drugging Dementia Patients

Tuesday, March 1st, 2011

“Beautiful young people are accidents of nature, but beautiful old people are works of art.” — Eleanor Roosevelt

Natural News,  March 1, 2011

by Monica G. Young

Pharmaceutical companies view the elderly as a lucrative market. However a panel of experts at the recent Senate Aging Committee forum decided to speak up. Over-medication occurs far too often in those diagnosed with dementia, the panel warned, and as baby boomers age the problem will only worsen.

One reason overmedication occurs, per this panel, is family members, caregivers, and nursing home workers often misinterpret patients’ complaints about physical ailments as unruly or aggressive conduct. To manage their behavior, such patients are administered antipsychotics they don’t need.

About five million patients are currently diagnosed with Alzheimer’s and other forms of dementia. “Those in this field have a feeling we’re headed in a very fast train toward the end of a cliff,” stated Patricia Grady, PhD, director of the National Institute of Nursing Research.

Director of California Advocates for Nursing Home Reform, Patricia McGinnis, demanded nursing homes be held “accountable” for the drugs they administer. “The way anti-psychotic drugs are used in nursing homes is a form of elder abuse,” she told the forum. “Instead of providing individualized care, many homes indiscriminately use these drugs to sedate and subdue residents.”

McGinnis urged for more informed consent before antipsychotics are given. She cited her own 89-year-old mother who was hospitalized for a broken hip, discharged to a nursing home and given an antipsychotic. McGinnis said her mother did not have dementia and didn’t need the drug, and family members were never consulted.

Professor of Nursing at the University of Wisconsin, Christine Kovach, spoke of an elderly patient who kept saying “No, no, no” and protesting whenever someone tried to move her. She was put on an anti-psychotic. X-rays later disclosed an untreated broken hip.

Nonpharmacological approaches can help, said Laura Gitlin, PhD, Director of the Jefferson Center for Applied Research on Aging and Health in Philadelphia. She listed alternatives like personal counseling, education, skill training of family members, and simple and engaging activities.

Antipsychotics have been widely used to squelch disruptive behavior among people with dementia. However these drugs are especially life-threatening to older people, raising the risk of strokes, diabetes and falls.

“There’s a bunch of problems, not least of which is those drugs can kill you,” reported Dr. Mark Kunik at Baylor College of Medicine in Houston at the annual Gerontological Society of America’s meeting. Instead of looking for physical causes of disruptive behavior, doctors typically prescribe drugs for dementia patients, he said, because “It’s the easy thing to do. … That’s true in hospitals, in clinics and in nursing homes.”

“Whether you have Alzheimer’s or not, there’s a reason people get frustrated or upset — pain, urinary tract infections, hunger, fear of strangers or loud noises or strange settings, maybe drug interactions,” Kunik stated. “If you figure that out, you likely can find a safer, nonpharmacologic treatment.”

There are alternatives that work. Eva Lanigant, a resident care coordinator for a facility in Minnesota, was tired of seeing elderly patients drugged into a stupor. Working with a psychiatrist and a pharmacist, she started a project to replace drugs with massage, games, exercise, personal attention, better pain control and other techniques. They trained the entire staff to interact with dementia residents.

Within six months they eliminated antipsychotic drugs and cut antidepressant use by half. Lanigan reported, “The chaos level is down, but the noise is up: the noise of people laughing, talking, much more engaged with life.  It’s amazing.”

« Return to news items


Share

Federal Judge & DOJ back lawsuit accusing Johnson & Johnson of illegal kickback scheme to push antipsychotic drugs on elderly

Tuesday, March 1st, 2011

AboutLawsuits.com

March 1, 2011

A federal judge has refused to toss out a whistleblower lawsuit backed by the Department of Justice (DOJ), which accuses Johnson & Johnson of involvement in an illegal kickback scheme to push their antipsychotic drugs on elderly nursing home residents that did not need them.

Johnson & Johnson sought to have claims brought by the DOJ, a number of whistleblowers and states dismissed, saying that what the plaintiffs are calling illegal kickbacks were completely legal rebates. However, U.S. District Judge Richard Stearns found that plaintiffs had sufficient evidence to go forward with the complaint.

Judge Stearns did remove several plaintiffs from the case, including the states of Nevada, Texas and Illinois, but allowed Kentucky, Indiana and Virginia to stay part of the lawsuit. Whistleblower David Kammerer was also removed from the lawsuit.

The DOJ filed a civil False Claims Act compliant against J&J on January 15, 2010, saying that the company paid millions to Omnicare, Inc. as kickbacks for selling Risperdal to nursing home patients.

In 2009, Omnicare settled charges brought against it by the government for allegedly paying kickbacks to nursing homes to prescribe the drug. At that time, the Justice department investigators indicated that the illegal nursing home drug kickbacks were hidden as data fees, education fees and as payments to attend Omnicare meetings.

According to the DOJ complaint against Johnson & Johnson, the drug maker paid $50 million to Omnicare between 1999 and 2004 to get it to prescribe Risperdal to elderly patients with dementia, and then hid those kickbacks as payments for services that Omnicare never actually provided. Omnicare then enacted intervention programs such as the “Risperdal Initiative” to persuade physicians to prescribe the drug to elderly dementia patients.

Omnicare, the largest pharmaceutical supplier for nursing homes in the U.S., has pharmacists on staff who review patients’ records and then makes recommendations to the patients’ physicians. Those recommendations are followed about 80% of the time, the DOJ said.

The claims were originally made by Omnicare pharmacist Bernard Lisitza in 2003, and the DOJ chose to intervene on Lisitza’s behalf.

Whistleblowers who report a false claim against the government may be entitled to receive a portion of any money that the government recovers from the offenders under the qui tam provision of the False Claims Act. In return, the whistleblower must be the first to bring the case to the government’s attention, and must not publicize the claim until the DOJ decides to prosecute the claim.

Risperdal (risperidone) is manufactured by Janssen, a division of Ortho-McNeil-Janssen, which is a subsidiary of Johnson & Johnson. Risperdal is approved by FDA for the treatment of schizophrenia, bipolar disorder and autism, but it is commonly used among elderly with dementia and sometimes as a form of chemical restraint in nursing homes.

Risperdal is not approved for treatment of dementia, and patient advocates have been pushing nursing homes to reduce the use of the drug among elderly due to the health risk and a lack of actual health benefits. According to a recent report from the United Kingdom, side effects of Risperdal and other similar antipsychotics, like Seroquel, Zyprexa and Abilify, could be linked to as many as 1,800 deaths and 1,620 strokes per year in elderly patients with dementia.

http://www.aboutlawsuits.com/risperdal-omnicare-lawsuit-proceeds-16571/

To see more international drug regulatory warnings and studies on Risperdal and other antipsychotic drugs, visit CCHR’s Psychiatric Drug Side Effects Database here: http://www.cchrint.org/psychdrugdangers/drug_warnings.php

« Return to news items


Share

Not the Only Psychiatrist Who Opposes ECT

Wednesday, January 26th, 2011

The Huffington Post – January 26, 2011

by Dr. Peter Breggin

Peter R. Breggin, MD is a psychiatrist in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books. His first medical book was about ECT: Electroshock: Its Brain-Disabling Effects (1979).

Duff Wilson provided a service by presenting both sides of the controversy when he wrote his report “F.D.A. Is Studying the Risk of Electroshock Devices” in the January 24, 2011 New York Times. The FDA is proposing to move ECT from the high risk category to the medium risk category to avoid the necessity of any testing for safety or efficacy. As a result, ECT would be grandfathered into continued use without ever being tested. This would place ECT in the same category as syringes which no longer need proof of safety or efficacy. The FDA hearings will be held January 27-28, 2011, and I hope some of my more courageous colleagues will attend and testify against approving ECT without testing.

Mr. Wilson quotes me correctly in the article: “It’s a big money-maker,” he [Breggin] said. “I would say if anything it’s been on the increase because there’s a market that’s been exploited, that is the elderly depressed women on Medicare. The reason for that is they’re covered, and there’s no one to protect them. What commonly stops shock treatment is a family member saying ‘over my dead body.’ ”

However, Mr. Wilson misunderstood what I meant to say when, without quoting me, he wrote in the original published edition that Breggin “says he is the only American psychiatrist he knows who opposes the treatment.” He and I have chatted since the publication of his article in the NYT and he has generously edited the current on-line copy of the article and posted a correction indicating that I actually said that I am the only psychiatrist I know of who publicly opposes the treatment. I don’t know anyone else who has taken a very visible public stand–publishing anti-ECT views in the scientific literature, and presenting them in the media and the courts. Similarly, I am the only psychiatrist to have testified in a successful ECT malpractice suit.

The same was true when I conducted my successful campaign to stop the resurgence of lobotomy and other forms of psychosurgery in the 1970s. At that time, most psychiatrists probably opposed lobotomy, but I was the first and still only one to oppose it publically in the scientific literature, the media, and the courts, as well as in Congressional testimony. The success of my campaign required putting outside pressure on facilities, psychiatrists and neurosurgeons who were involved in this barbaric “treatment” and cutting off federal funding for some of their projects. I’m also the only psychiatrist to testify in a successful psychosurgery malpractice trial. My reform efforts against ECT and lobotomy are described Brain-Disabling Treatments in Psychiatry (2008, p. 230-232), ECT is especially harmful to the more fragile brains of the elderly.

ECT causes closed head injury by means of electrically-induced seizures. There can be no doubt that the treatment causes trauma to the brain. The patient is comatose for several minutes in the recovery room and after a few treatments becomes confused and disoriented. A recent study confirms long-term memory loss and other cognitive deficits, which by definition is dementia. As I review in Brain-Disabling Treatments in Psychiatry (2008, pp. 237-241), large animal studies have shown brain cell death using ECT dosages less than those routinely inflicted today. My website has a very extensive ECT bibliography that can be downloaded for free. It includes a variety of the original large animal ECT research projects.

After John Read and Richard Bentall published their recent scientific review, Professor Bentall declared, “The very short- term benefit gained by a small minority cannot justify the risks to which all ECT recipients are exposed. The use of ECT therefore represents a failure to introduce the ideals of evidence-based medicine into psychiatry. It seems there is resistance to the research data in the ECT community, and perhaps in psychiatry in general.”

In a sane society, ECT would be abandoned as a treatment. In an insane society, a government agency would approve it without requiring testing for safety and efficacy. That may be about to happen.

Peter R. Breggin, MD is a psychiatrist in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books. His first medical book was about ECT: Electroshock: Its Brain-Disabling Effects (Springer Publishing Company, New York, 1979). His most recent medical book dealing with ECT is Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock and the Psychopharmaceutical Complex, Second Edition (2008). Dr. Breggin’s professional website is www.breggin.com.

You can meet and hear presentations by Dr. Breggin and some of his closest colleagues at the annual Empathic Therapy Conference to be held April 8-10, 2011 in Syracuse, New York. Click here to learn more about the conference and to register. Professionals and non-professionals alike are welcome.

http://www.huffingtonpost.com/dr-peter-breggin/not-the-only-psychiatrist_b_813863.html

« Return to news items


Share

Now this, is the kind of mental therapy we can get behind—”Psychiatrist tries a different approach with dementia patients”

Tuesday, January 4th, 2011

STAFF PHOTO / CRAIG LITTEN - Dr. Miguel Rivera visits with patient Helen Kidd last month at the Pines of Sarasota. Under Rivera's direction, Pines caregivers have deployed some simple spa comforts to reduce agitation. As a result, dosages of antipsychotic drugs have dropped.

Herald Tribune
By Barbara Peters Smith
January 2, 2011

The pixie-like patient in a pink dress and a long, flirty strand of pearls lights up as visitors approach, and scoots her wheelchair along the corridor to give them her standard greeting.

“Okinawa! Saipan! Iwo Jima! Rome!” she chirps, alluding to the military career that took her around the world — long before dementia brought her here, to the Garden Memory Unit at Pines of Sarasota.

She tags along as the visitors inspect a shower room that has been freshly painted with an expansive scene of Gulf-front sand and sky. Isn’t that the most beautiful thing you’ve ever seen?” she asks them. “I love it in there!”

One of the Pines’ calming shower rooms.

Dementia patients can get anxious to the point of violence while bathing, and this cheery beach mural is one of many small innovations that have lifted moods here in recent months. Under the direction of psychiatrist Dr. Miguel Rivera, caregivers at the Pines have deployed such simple spa comforts as music, massage and calming colors to help reduce agitation. As a result, dosages of antipsychotic medications have dropped to less than half the state average for this most challenging patient population.

Rivera, a gentle, sweet-spoken native of Puerto Rico who completed his psychiatric residency at the University of South Florida in 2001, stresses that none of these therapeutic tactics are his own invention.

“These were not things they taught us in our residency program, but I didn’t create them, either,” he says. “I’m more the person that maybe has the credentials to bring this to people, and people will tend to believe me because I have this M.D. behind my name.”

But Pam Polowski, the Alzheimer’s Association program specialist for Sarasota County, says Rivera works a kind of magic that is rare in this field.

“One of the things that is really important to know is that we can’t drag our dementia patients into our world,” Polowski says. “We have to go to their world and join them on that journey. And he gets that.”

Dementia is a loss of brain function that cripples memory, emotions and behavior. Medicare payments for services to dementia patients are expected to total $172 billion in 2010. So low-cost interventions such as Rivera’s could save tax dollars.

In a light-filled common room at the Pines, activities director Shirley Riesz is using karaoke to help 20 or so residents power through the normally trying hours before suppertime. Dementia patients’ circadian rhythms can make them prone to “sundowning,” Rivera explains, when they “begin to pace, get aggressive, want to go home and set off alarms” on the unit’s doors to the outside world.

A music therapy session at any long-term care facility can be a dreary, halfhearted ritual. But here, the atmosphere is alive. As “High Hopes” plays, Riesz holds the microphone for a man who sings out strongly, “Whoops, there goes another rubber tree plant!”

Even those not joining in are attentive and mostly smiling. Several wave at Rivera, and he waves delightedly back.

“They don’t know I’m a doctor,” he said, indicating his casual, golf-style shirt. “They just think I’m this friendly guy who comes around a lot.”

Through research and trial and error, Rivera has discovered that what he calls “courting music” — from the days when his patients were young and in love — evokes the most dramatic responses. He explains that the vivid connection between a particular song and a potent emotion reflects “things that the mind doesn’t really know. If you are really able to concentrate and visualize through music, you get transported and the body responds.”

Rivera tells the story of Ann, who moved to the memory unit from the assisted-living section of the Pines after a stroke. Unable to speak, she was despondent and withdrawn.

“I had the intuition that what we really needed to do was to start her on a singing program,” he recalls. “We started to notice early on that she was able to sing words and phrases that she was not able to speak. Little by little, it started to spill into her day. She started saying ‘OK’ or ‘yes’ or ‘no.’ We never knew that she liked coffee until the other day, when she told Shirley, ‘I love coffee.’ So now she gets to enjoy her coffee.”

And there is Grace, the patient so upset by the bathing process that she was giving her attendant bruises.

“This is a Monday ritual without fail,” Riesz wrote in a recent e-mail message to Pines education director Joann Westbrook. “But today there was NO screaming, just laughing, dancing and singing.”

The song that did the trick, according to certified nurse assistant Valrie Miller, was “Will You Love Me Tomorrow?” After the first nonviolent bath time, Miller says, Grace asked her, “Will you love me today?”

Thanks to a small grant that paid for iPods and “courting music”; waterproof plastic iPod holders made by Rivera’s neighbor, a retired engineer; and those calming beach scenes painted by Westbrook’s husband, K.C. Higgins, the Pines found a way to do for Grace what the strongest pharmaceuticals could not.

“What is ironic,” Riesz added, was that “her daughter gave me a preferred music CD and it has no connection or relation to the genre she was enjoying. Let that be a lesson to us: Make up your preferred playlist of music now, because someday your children may do it for you.”

Rivera, who works as a mental health medical director for seven long-term care facilities in Sarasota, did not plan any of this.

He came to Sarasota in 2001 with what he now calls the “grandiose” idea of running an alternative, yoga-based medical practice that would “teach people how to change their lives.” The business failed.

“Right around the same time that this is disappearing,” he says, “I get a call from Bruce Robinson, the chief of geriatrics at Sarasota Memorial. And he said, ‘Hey, I heard you were in Sarasota; would you mind doing some nursing home consultations for me?’ They say in Spanish, when you’re born to be a hammer, it rains nails from the skies.”

Robinson says finding trained psychiatrists to take on this work is a struggle.

“There’s a desperate need for more mental health care in long-term facilities,” he says. “It’s a shame there aren’t more doctors like Miguel. He’s there. He answers his phone.”

Rivera took to his mission right away. But he was frustrated that his only option for helping distraught patients was to increase their medications.

“I remember so many times walking through that old west hallway at the Pines” before the building was remodeled, he says. “After the first few years of me working there and seeing how people were overmedicated, and boredom was so prevailing, I remember — and I feel it right now — just walking down that hall, and praying, saying, ‘Please, God, show me a way.’ ”

It was Rivera’s wife, Natasha, he says, who put him on a path to exploring alternatives to drugs. Both practitioners of TriYoga, they met in 2007 on a spiritual trip to India. By the end of the three-week stay, they were married. A year later, she joined him in Sarasota from her native Russia. And almost immediately, Rivera says, she changed the way he was doing his job.

“All of a sudden there is this fresh pair of eyes that is asking all these questions,” he says. “‘What is Alzheimer’s disease? Why do people get it?’ It made me look at things; it took me out of that automatic mode.”

Rivera soon found research on the use of music, massage and other therapies on dementia patients. His reading also led to the use of daily affirmations by Pines staffers, who tell the patients, “You are safe; you are loved; you are happy.” The result, says Westbrook of the Pines, was “this whole beautiful circle he has created here that has changed that unit.”

Robinson views Rivera’s work from a more scientific standpoint, and applauds the fact that out of some 40 patients in the Pines memory unit, only eight are taking antipsychotic drugs.

“I am happy to have them report that,” he says. “Since the only evidence we have for the effects of antipsychotics is that they kill people, anything that can reduce that is a good thing.

“The life of an old person with dementia can be very meager: Where’s the fun?” Robinson adds. “The idea of having something positive in your life, like massage — all those things have an evident face validity.”

Read the rest of the article here:  http://www.heraldtribune.com/article/20110102/ARTICLE/101021037/2055/NEWS?p=1&tc=pg

« Return to news items


Share

The Way Antipsychotics Are Used in Nursing Homes Called “A form of elder abuse” by Patient Advocates

Monday, December 13th, 2010

NurseWeek—Dec 13, 2010

Over-medication of dementia patients is a looming problem as the number of such patients in the U.S. continues to grow, a panel of experts told a Senate Aging Committee forum on Dec. 8.

Panelists said over-medication, sometimes with anti-psychotic drugs, frequently occurs with dementia patients because caregivers or family members may mistake complaints of physical illness for unruly behavior.

Patricia McGinnis, executive director of the California Advocates for Nursing Home Reform, said nursing homes must be “accountable” for the drugs they administer.

“The way anti-psychotic drugs are used in nursing homes is a form of elder abuse,” McGinnis told the forum. “Instead of providing individualized care, many homes indiscriminately use these drugs to sedate and subdue residents.”

By learning more about residents to understand their needs and personalities, and establishing work schedules that allow staff to consistently work with the same residents, according to panelists, nursing homes can reduce the use of drugs as a solution to unruly behavior by dementia patients.

Non-drug approaches also can be helpful for caregivers, according to panelist Laura Gitlin, PhD, director of the Jefferson Center for Applied Research on Aging and Health at Thomas Jefferson University in Philadelphia.

She said that providing at-home caregivers with specific skills training in stress reduction, communication and problem-solving techniques can reduce depression and improve self-rated health, sleep quality and overall well-being.

Gitlin described an occupational program at her university that developed meaningful activities for dementia patients based on their capabilities. The program cost $941.63 per family per year, compared with $1,825 for drug treatment programs. The program also saved caregivers about five hours a day in time they would have otherwise spent in hands-on care.

http://news.nurse.com/article/20101213/NATIONAL02/112130006/-1/frontpage

« Return to news items


Share

Nursing homes are seeking to end the psychiatric drug stupor

Sunday, December 5th, 2010

Note from CCHR: The wholesale psychiatric drugging of the elderly in both private and public nursing homes has reached epidemic levels, with the use of antipsychotics, antianxiety drugs (tranquilizers) and antidepressants  skyrocketing and patients being harmed and killed as a direct result.  These drugs are highly dangerous when prescribed to anyone, but when prescribed to the elderly the risks for diabetes, stroke and sudden death are greatly increased.    As stated in the article below, ” Instead of looking for causes of disruptive behavior among dementia patients, doctors typically prescribe drugs to mask the symptoms… because it’s the easy thing to do. … That’s true in hospitals, in clinics and in nursing homes.” It is for this reason we feel the more humane non-drug approach being undertaken by this particular chain of nursing homes in treating elderly patients  suffering from dementia should not only be commended, but employed by all nursing homes caring for the elderly.

The Star Tribune – Dec 4, 2010

by Warren Wolfe

Instead of treating behavioral problems with antipsychotic drugs, the Ecumen chain of 15 homes is using strategies including aromatherapy, massage, music, games, exercise and good talk. The state is helping out.

The aged woman had stopped biting aides and hitting other residents. That was the good news.

But in the North Shore nursing home’s efforts to achieve peace, she and many other residents were drugged into a stupor — sleepy, lethargic, with little interest in food, activities and other people.

“You see that in just about any nursing home,” said Eva Lanigan, a nurse and resident care coordinator at Sunrise Home in Two Harbors, Minn. “But what kind of quality of life is that?”

Working with a psychiatrist and a pharmacist, Lanigan started a project last year to find other ways to ease the yelling, moaning, crying, spitting, biting and other disruptive behavior that sometimes accompany dementia.

They wanted to replace drugs with aromatherapy, massage, games, exercise, personal attention, better pain control and other techniques. The entire staff was trained and encouraged to interact with residents with dementia.

Within six months, they eliminated antipsychotic drugs and cut the use of antidepressants by half. The result, Lanigan said: “The chaos level is down, but the noise is up — the noise of people laughing, talking, much more engaged with life. It’s amazing.”

Now the home’s operator, Shoreview-based Ecumen, has started a project called Awakenings throughout its 15 long-term care nursing homes. It’s based on Lanigan’s work and funded with a two-year, $3.7 million state grant.

“We saw what Eva was doing — something everybody in the industry talks about — and we were impressed,” said Mick Finn, an Ecumen vice president. “We said, ‘Hey, this is real. Can we all do this?’ ”

The dangers of drugs

Powerful antipsychotic drugs have been used for years to reduce agitation, hallucinations and other debilitating symptoms among people with mental illnesses.

They also are widely used “off label” to quell disruptive behavior among people with Alzheimer’s disease and other forms of dementia.

Medicare spends more than $5 billion a year on those drugs for its beneficiaries, including about 30 percent of nursing home residents. Several studies have concluded that more than half are prescribed inappropriately. The drugs are especially hazardous to older people, raising the risk of strokes, pneumonia, confusion, falls, diabetes and hospitalization.

“There’s a bunch of problems, not least of which is those drugs can kill you,” said Dr. Mark Kunik at Baylor College of Medicine in Houston who spoke last month at the Gerontological Society of America’s annual meeting in New Orleans.

Instead of looking for causes of disruptive behavior among dementia patients, doctors typically prescribe drugs to mask the symptoms, he said, because “It’s the easy thing to do. … That’s true in hospitals, in clinics and in nursing homes.”

Federal regulators are cracking down on homes that don’t routinely reassess residents on psychotropic drugs. But use remains widespread.

“Whether you have Alzheimer’s or not, there’s a reason people get frustrated or upset — pain, urinary tract infections, hunger, fear of strangers or loud noises or strange settings, maybe drug interactions,” Kunik said. “If you figure that out, you likely can find a safer, nonpharmacologic treatment.”

Treating loss with love

About 150 miles south of Two Harbors, Bernice Brockelman, 91, was snacking on cookies last Wednesday beside the Christmas tree at Ecumen Parmly LifePointes, a nursing home in Center City — all the while alternating quickly from calm to worry to calm.

“Can I stay here tonight? I don’t know where to go. Can I stay with you?” she asked Christy Johnson, the home’s therapeutic recreation director. Though Johnson reassured her, she asked the question again — and again and again.

In an effort to calm her while preparing to wean her from pills, the Parmly staff invited Brockelman into a game of Bingo and to recite the Polish phrases she learned from her immigrant parents. Then she spotted a male visitor.

“Hey, is he married?” she asked with a sparkle in her eye.

“When she’s feeling good, Mom’s an outrageous flirt and she can be really funny,” said her daughter, Judy Balthazor of Center City. “But often there is the repetitive questions, the worry, sometimes just being washed out. I can’t wait for them to get her off her drugs.”

Until the Awakenings project, few at the home knew Brockelman’s whole story — the loss of both parents when she was in high school, of her husband at age 46, then two sons, a close friend and a nephew. Found to have psychosis and dementia, she “just shut down because she had so many losses,” Balthazor said.

Now, the Parmly staff is gaining deeper knowledge of 15 residents who are on psychotropic drugs and who frequently are agitated or upset. They are about to start weaning the residents from the drugs, but they’ve already started a range of activities tailored to each.

Some say nursing homes cannot afford to replace drugs with personal attention because it requires too much staff time.

“Our guess is that it will take the equivalent of two extra people at each home, spread across all job categories,” said Finn, Ecuman’s vice president. “Can we afford it? We think we have to, because it’s the right thing.”

Brockelman, who lived nearly all of her life in northeast Minneapolis, loved to bake, so now she helps make bread and cookies. She danced and was physically active, so she walks with an aide and taps her toes to polka music. A devout Catholic, she attends several weekly church services. She plays Bingo with aide Jenna Miller and sometimes other residents.

“When [you] understand who Beatrice has been in the past, you know her a lot better in the present,” Miller said. “With the Awakenings project, I have permission to spend the time I need with Bernice so she feels safe and loved.”

http://www.startribune.com/lifestyle/health/111326224.html?page=1&c=y

« Return to news items


Share

‘Curb dangerous chemical cosh drugs for dementia victims’

Tuesday, October 26th, 2010
dementia
Daily Mail
October 26, 2010
by Louise Eccles

An alliance backed by the government has promised to cut back on the use of dangerous ‘chemical cosh’ drugs for dementia sufferers (posed by model)

An alliance backed by the Government has promised to cut back on the use of dangerous ‘chemical cosh’ drugs for dementia sufferers.

In an unprecedented move, a coalition of 45 public and private bodies and charities has pledged to transform the way patients are treated and drive down the use of anti-psychotic drugs.

Experts have argued that the ‘chemical cosh’, recommended for short-term use to calm down people who are agitated, has been widely over-prescribed for dementia sufferers in an attempt to keep them quiet, particularly in care homes.

Studies have shown patients who take the drugs over a long period are twice as likely to die early as those who do not. Approximately 144,000 sufferers are prescribed anti-psychotics in care homes, causing 1,800 deaths annually.

Research shows that people taking them are three times as likely to have a stroke and they are more likely to go into long-term decline.

Now, the newly-created Dementia Action Alliance has committed to drive down use of the drugs.

Supported by the Department of Health, the alliance includes the Royal College of GPs, the Royal College of Psychiatrists, Age UK, Nice, Bupa, the Alzheimer’s Research Trust, the Alzheimer’s Society and several major care home groups, among others.

The reduction in anti-psychotics is one of seven aims put forward by the alliance on behalf of patients and carers who are seeking more control over treatment and to be made to feel more valued.
Read more: http://www.dailymail.co.uk/health/article-1323791/Curb-chemical-cosh-dementia-victims.html#ixzz13VgBIhij

« Return to news items


Share

Science Daily: Almost 1/3 of U.S. nursing home residents received antipsychotic drugs as chemical restraints

Wednesday, June 2nd, 2010

Illinois Nursing Home Abuse Blog
By Levin & Perconti

Science Daily is reporting that a study shows that newly admitted elderly patients to nursing homes have a higher rate of being prescribed antipsychotic drugs than in previous years. This study found that in 2007, almost one-third of U.S. nursing home residents received antipsychotic drugs. The FDA has issued a warning that there is a great risk of death among older adults with dementia who are taking these agents to control behavioral symptoms. A recent clinical trial has concluded that the adverse effects of atypical antipsychotic drugs have outweighed the benefits of those with Alzheimer’s. This shows that many doctors are over prescribing these drugs, and it is having an adverse effect on patients.

The nursing home study found that about 30 percent of the residents in the study received at least one antipsychotic medication in 2006 and 32 percent of those did not have dementia or another indication that they needed to be on this medication. Some experts believe that the organizational culture of the nursing homes may encourage the prescribing of antipsychotic. Hopefully, the FDA warning and other studies will move the prescription statistics in the opposite direction. If not policies may have to target those nursing homes that have a high antipsychotic prescription rate so as to improve patient care. To read more about the nursing home study, please click the link.

Read entire article:  http://blog.levinperconti.com/2010/05/antipsychotic_medications_are.html

« Return to news items


Share

Earth Times: Neurologist Fred Baughman—Vets Sudden Deaths Due to Antidepressant & Antipsychotic Drugs

Monday, May 24th, 2010

EarthTimes.org
By Fred A. Baughman, Jr.
May 24, 2010

Fred A. Baughman Jr., MD today announced the results of his research into the “series” of veterans’ deaths acknowledged by the Surgeon General of the Army.

Upon reading the May 24, 2008, Charleston (WV) Gazette article “Vets Taking Post Traumatic Stress Disorder Drugs Die in Sleep,” Baughman began to investigate why these reported deaths were “different.”  And, why they were likely, the “tip of an iceberg.”

Andrew White, Eric Layne, Nicholas Endicott and Derek Johnson were four West Virginia veterans who died in their sleep in early 2008. Baughman’s research suggests that they did not commit suicide and did not “overdose” leading to coma as suggested by the military.  All were diagnosed with PTSD.  All seemed “normal” when they went to bed.  And, all were on Seroquel (an antipsychotic) Paxil (an antidepressant) and Klonopin (a benzodiazepine).

They were not comatose and unarousable ? with pulse and respirations or pulse intact, responsive to CPR, surviving transport to a hospital, frequently surviving.  These were sudden cardiac deaths.

At the time, Stan White, father of Andrew White knew of eight such cases in Kentucky, Ohio and West Virginia.

In a February 7, 2008 interview with the Chicago Tribune, Lt. Gen. Eric B. Schoomaker, the Army’s surgeon general, said there has been “a series, a sequence of deaths” in the new “warrior transition units.”

In April 2005, the FDA warned that Seroquel put elderly patients with dementia-related psychosis at increased risk of death.

On January 15, 2009, Ray et al, reported that antipsychotics double the risk of sudden cardiac death.  On March 17, 2009, Whang et al reported that antidepressants, as well, increase the rate of sudden cardiac deaths.

And yet, in an August 14, 2008 analysis of two of the four Charleston-area deaths, the Inspector General for Veterans Affairs concluded (Report No. 08-01377-185): “Although antipsychotic medications have been identified as possible causes of cardiac rhythm disturbances, a 2001 review…found no association with olanzapine (Zyprexa), quetiapine (Seroquel), or risperidone (Risperdal) and Torsades de Pointes (a fatal heart rhythm) or sudden death… we are unaware of any clinical practice guidelines recommending baseline or periodic electrocardiogram monitoring in young, healthy patients on quetiapine (Seroquel).”

However, in a literature review covering the years 2000-2007, entitled Sudden Cardiac Death Secondary to Antidepressant and Antipsychotic Drugs: [Expert Opinion on Drug Safety; 2008, Number 2, March 2008 , pp. 181-194(14)] Sicouri and Antzelevitch conclude: (1) “A number of antipsychotic and antidepressant drugs can increase the risk of ventricular arrhythmias and sudden cardiac death?” (2) “Antipsychotics can increase cardiac risk even at low doses whereas antidepressants do it generally at high doses or in the setting of drug combinations,” and (3) “These observations call for?an ECG at baseline and after drug administration.”

Read entire article:  http://www.earthtimes.org/articles/show/fred-a-baughman-jr-md,1312839.shtml

« Return to news items


Share